Covishield version of AstraZeneca Jab

Starting to delve into the strange happenings related to collaboration between AstraZeneca and The Serum Institute of India

Covishield is a hot topic for hundreds of millions of Jabbees.

Starting my delve into its Harms.

There is the question about where the Covishield was manufactured when Emergency Use Authorization was sought in Europe.¹

Covishield was not accepted for the EU travel pass when over 300,000,000 people had been jabbed.²

There are reports that jab certificates carried a propaganda message from the PM.³

There was a WHO alert put out that Fake versions of Covishield were circulating in Uganda, India and Myanmar.⁴

Unfortunately the US CTD has Zero entries for Covishield or AstraZeneca Harms, but note that one might request curation. Perhaps a lawyer could do that?

We know hundreds of peer-reviewed papers on the AstraZeneca jab have been published.

I have a large AstraZeneca collection thanks to the New South Wales Health Department Critical Intelligence Unit weekly broadcasts, but I want to focus on the version with the Covishield Label. Click on image to expand.

A number of other authors have written about Covishield here on Substack, so I will add them as references later if relevant to Harms.

Harms caused by Covishield

A small study from India by jab enthusiasts looked at Covid19 patients who were jabbed versus unjabbed in the Princess Krishnajammanni Trauma Care Centre (PKTCC), Mysore, which was converted to a designated COVID hospital between April 2021 to July 2021.⁵

Jabbed patients suffered more Vomiting, with 3.9% and 4.3% of single or fully vaccinated patients reported vomiting compared to 1.3% of patients who had not received any vaccines. The authors did not understand why, but I can point to the likely cause.⁶

A 2021 paper concentrated on Adverse Events reported from the 1st dose of Covishield given to 358 government officials. It was conducted by online survey from 3rd to 10th February 2021 with a list of solicited symptoms.⁷

• Pain

• Dizziness

• Headache

• Body Ache

• Fever

• Chills

• Palpitations

• Perspiration

• Intra-oral Ulcers

• Taste Change

• Rashes on Skin

• Runny Nose

• Neck Stiffness

Females were found to experience adverse events more than males, and younger people suffered more.

Deaths from Covishield

Recently there has been renewed Legal Action in India by relatives of people killed by Covishield and a new website established for jab victims and their families to report adverse events.⁸

The recent admission in UK and elsewhere that AstraZeneca directly caused Deaths should assist Covishield claimants.

We can find a few Covishield jab victims mentioned in the mandatory Periodic Safety Update Reports from AstraZeneca.⁹¹⁰

See the expected¹¹ Rapid onset Autoimmune Hepatitis with some clinical data.

Eye Damage was common within days of Covishield. This is one case of many discussed in the PSURs based on peer-reviewed case studies.

Singh et al 2022¹² ( case ID Redacted) In this case report article authors present a case of herpes simplex (HSV) retinitis in 29-year-old male two days following the first dose of the Covishield vaccine. Since the blood serologies were all negative, a diagnostic vitrectomy was performed and the vitreous sample for viral PCR came positive for HSV-1 . At 6-week follow-up, the patient improved with a near-complete resolution ofretinitis after the course of antiviral therapy.

AstraZeneca comment: There is a limited information on patient concomitant medications, medical history, and presence of any alternate viral reactivation triggers that precluded a proper assessment. The case was assessed as Possible (with limited information) according to WHO-UMC criteria.

We know Endotoxin triggers Dormant Virus reactivation.¹³ Blindness often follows in one or both eyes.¹⁴

I look forward to reading your Covishield contributions and expanding later.

1. https://www.bbc.com/news/world-asia-india-57633980

2. https://qz.com/2026656/the-eu-digital-covid-certificate-excludes-the-covishield-vaccine

3. https://thewire.in/government/india-only-nation-to-use-covid-vaccination-certificate-to-push-cult-of-leader-ruling-party

4. https://www.lowyinstitute.org/the-interpreter/blockchain-solution-covid-19-vaccine-scams

5. Ganesh Korishettar, Prashanth Chikkahonnaiah, SubbaRao V. Tulimilli, Siva Dallavalasa, Shashidhar H. Byrappa, SubbaRao V. Madhunapantula and Ravindra P. Veeranna. 2022. Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients.

6.

7. Srishti Jain, Sandhya Jain and S.V Sai Prasad. 2021. Coronavirus Vaccine: A Cross-Sectional Study of Its Adverse Events. https://www.researchgate.net/publication/355664459_Coronavirus_Vaccine_A_Cross-Sectional_Study_of_Its_Adverse_Events

8. Swati Bharadwaj. Kin claim deaths due to Covishield, to sue Serum Institute of India. https://timesofindia.indiatimes.com/city/hyderabad/kin-claim-deaths-due-to-covishield-to-sue-serum-institute-of-india/articleshow/110046824.cms

9. AstraZeneca. 28 February 2022. COVID-19 Vaccine (AZD1222) Periodic Benefit-Risk Evaluation Report.

10. AstraZeneca. 25 August 2022. COVID-19 Vaccine (ChAdOxl-S [recombinant]) Periodic Benefit-Risk Evaluation Report.

11.

12. Singh, J., A. More, S. B. Shetty, P. Chaskar,A. Sen. Herpes simplex virus retinitis following ChAdOxl nCoV- 19 (Covishield) vaccination for SARS CoV 2: A case report Ocular Immunology and Inflammation 2022.

13.

14.